(Q38175359)

30 August 2017

MicroRNA-targeting therapeutics for hepatitis C. (English)

1 reference

30 August 2017

1 reference

Jihae Baek

1

1 reference

30 August 2017

Soowon Kang

series ordinal

2

1 reference

30 August 2017

Hyeyoung Min

series ordinal

3

1 reference

30 August 2017

3 January 2014

1 reference

Archives of Pharmacal Research

30 August 2017

1 reference

30 August 2017

37

1 reference

30 August 2017

3

1 reference

30 August 2017

299-305

1 reference

https://scigraph.springernature.com/pub.10.1007/s12272-013-0318-9

30 August 2017

0 references

cites work

MicroRNAs: target recognition and regulatory functions

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

microRNAs in vertebrate physiology and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Evaluation of VCH-759 monotherapy in hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

New treatments for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Regulation of hepatitis C virus by microRNA-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Identification of tissue-specific microRNAs from mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Current and future therapies for hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Discovering the first microRNA-targeted drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Cytotoxic T-lymphocyte associated antigen 4 polymorphisms and asthma risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Interferon modulation of cellular microRNAs as an antiviral mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Response-guided telaprevir combination treatment for hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Hepatitis C virus infection, microRNA and liver disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Global control of hepatitis C: where challenge meets opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0318-9

10.1007/S12272-013-0318-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

0 references

1 reference